• Je něco špatně v tomto záznamu ?

The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability

C. Lobello, V. Bikos, A. Janikova, S. Pospisilova,

. 2018 ; 10 (3) : . [pub] 20180305

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc18009959

Genomic stability is crucial for cell life and transmitting genetic material is one of the primary tasks of the cell. The cell needs to be able to recognize any possible error and quickly repair it, and thus, cells have developed several mechanisms to detect DNA damage and promote repair during evolution. The DNA damage response (DDR) and DNA repair pathways ensure the control of possible errors that could impair the duplication of genetic information and introduce variants in the DNA. Endogenous and exogenous factors compromise genomic stability and cause dysregulation in the DDR and DNA repair pathways. Cancer cells often impair these mechanisms to overcome cellular barriers (cellular senescence and/or apoptosis), leading to malignancy. NPM (nucleophosmin)-ALK (anaplastic lymphoma kinase) is an oncogenic tyrosine kinase that is involved in the development of anaplastic large cell lymphoma (ALCL). NPM-ALK is known to be involved in the activation of proliferative and anti-apoptotic signaling pathways. New evidence reveals that NPM-ALK translocation also impairs the ability of cells to maintain the genomic stability through both DDR and DNA repair pathways. This review aims to highlight the role of the oncogenic tyrosine kinase NPM-ALK in the cell, and pointing to new possible therapeutic strategies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18009959
003      
CZ-PrNML
005      
20190114091325.0
007      
ta
008      
180404s2018 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/cancers10030064 $2 doi
035    __
$a (PubMed)29510549
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Lobello, Cosimo $u Central European Institute of Technology (CEITEC), Masaryk University, Kamenice 5, 62500 Brno, Czech Republic. cosimo.lobello@ceitec.muni.cz.
245    14
$a The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability / $c C. Lobello, V. Bikos, A. Janikova, S. Pospisilova,
520    9_
$a Genomic stability is crucial for cell life and transmitting genetic material is one of the primary tasks of the cell. The cell needs to be able to recognize any possible error and quickly repair it, and thus, cells have developed several mechanisms to detect DNA damage and promote repair during evolution. The DNA damage response (DDR) and DNA repair pathways ensure the control of possible errors that could impair the duplication of genetic information and introduce variants in the DNA. Endogenous and exogenous factors compromise genomic stability and cause dysregulation in the DDR and DNA repair pathways. Cancer cells often impair these mechanisms to overcome cellular barriers (cellular senescence and/or apoptosis), leading to malignancy. NPM (nucleophosmin)-ALK (anaplastic lymphoma kinase) is an oncogenic tyrosine kinase that is involved in the development of anaplastic large cell lymphoma (ALCL). NPM-ALK is known to be involved in the activation of proliferative and anti-apoptotic signaling pathways. New evidence reveals that NPM-ALK translocation also impairs the ability of cells to maintain the genomic stability through both DDR and DNA repair pathways. This review aims to highlight the role of the oncogenic tyrosine kinase NPM-ALK in the cell, and pointing to new possible therapeutic strategies.
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Bikos, Vasilis $7 xx0231091 $u Central European Institute of Technology (CEITEC), Masaryk University, Kamenice 5, 62500 Brno, Czech Republic. vasileios.bikos@ceitec.muni.cz.
700    1_
$a Janikova, Andrea $u Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, 62500 Brno, Czech Republic. janikova.andrea@fnbrno.cz.
700    1_
$a Pospisilova, Sarka $u Central European Institute of Technology (CEITEC), Masaryk University, Kamenice 5, 62500 Brno, Czech Republic. sarka.pospisilova@ceitec.muni.cz. Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, 62500 Brno, Czech Republic. sarka.pospisilova@ceitec.muni.cz.
773    0_
$w MED00173178 $t Cancers $x 2072-6694 $g Roč. 10, č. 3 (2018)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29510549 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20190114091534 $b ABA008
999    __
$a ind $b bmc $g 1287444 $s 1006771
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 10 $c 3 $e 20180305 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
LZP    __
$a Pubmed-20180404

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...